![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Holdsworth M.T.
Publisher: Adis International
ISSN: 1174-5878
Source: Pediatric Drugs, Vol.5, Iss.7, 2003-01, pp. : 443-455
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Outpatient treatment of febrile neutropenia is viable
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 547, 2008-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Outpatient Therapy for Febrile Neutropenia: Clinical and Economic Implications
By de Lalla F.
PharmacoEconomics, Vol. 21, Iss. 6, 2003-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Levofloxacin prevents febrile episodes in neutropenia, cancer
Reactions Weekly, Vol. 1, Iss. 1070, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Chemotherapy induced febrile neutropenia: management and prevention
Clinical Medicine, Vol. 8, Iss. 4, 2008-08 ,pp. :